Both the biomarkers hs-cTnI and hs-cTnT are independently associated with hypertrophic cardiomyopathy; however, hs-cTnI provides robust information about cardiac hypertrophy [45]. This evidence concerns the gene TNNI3 and hypertrophic cardiomyopathy.